Interpreting the multi-biomarker disease activity score in the context of tocilizumab treatment for patients with rheumatoid arthritis

por Reiss, William G., Devenport, Jenny N., Low, Jason M., Wu, George, Sasso, Eric H.
Publicado 2015

Durability of Response to Tocilizumab Therapy in Rheumatoid Arthritis: Data from the US-Based Corrona Rheumatoid Arthritis Registry

por Pappas, Dimitrios A., Blachley, Taylor, Best, Jennie H., Zlotnick, Steve, Reiss, William G., Emeanuru, Kelechi, Kremer, Joel M.
Publicado 2021

Comparative Efficacy (DAS28 Remission) of Targeted Immune Modulators for Rheumatoid Arthritis: A Network Meta-Analysis

por Best, Jennie H., Kuang, Yuting, Jiang, Yilin, Singh, Rajpal, Karabis, Andreas, Uyei, Jennifer, Dang, Joseph, Reiss, William G.
Publicado 2021

Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia

por Salama, Carlos, Han, Jian, Yau, Linda, Reiss, William G., Kramer, Benjamin, Neidhart, Jeffrey D., Criner, Gerard J., Kaplan-Lewis, Emma, Baden, Rachel, Pandit, Lavannya, Cameron, Miriam L., Garcia-Diaz, Julia, Chávez, Victoria, Mekebeb-Reuter, Martha, Lima de Menezes, Ferdinando, Shah, Reena, González-Lara, Maria F., Assman, Beverly, Freedman, Jamie, Mohan, Shalini V.
Publicado 2020